TrialInternational journal of chronic obstructive pulmonary disease2012

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.

Donald P Tashkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.